Eli Lilly goes direct-to-consumer on weight loss drugs: What patients and investors need to know

Eli Lilly CEO on weight loss drugs outlook: Our top priority is making more product

Eli Lilly CEO: We're growing based on the back of our newest pharma products

Eli Lilly Alzheimer trial results update

Eli Lilly looking for smaller acquisitions: CEO

Jim Cramer: Eli Lilly stock represents real value

Eli Lilly is the best stock in pharma: Trader

Eli Lilly stock tumbles 10% after drug giant misses estimates and slashes profit guidance